Personal profile
Research interests
Targeting the DNA damage response in order to overcome chemotherapy resistance
Clinical interests
Surgical and medical management of gynecologic malignancies, as well as complex pelvic surgery.
Available to Mentor:
- PhD Students
Fingerprint
Dive into the research topics where Mary Mullen is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress (Mol. Cancer Res., (2026), 24, (198))
Mullen, M. M., Lomonosova, E., Toboni, M. D., Oplt, A., Cybulla, E., Blachut, B., Zhao, P., Noia, H., Wilke, D., Rankin, E. B., Kuroki, L. M., Hagemann, A. R., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Mutch, D. G., Powell, M. A., Mosammaparast, N., Vindigni, A. & Fuh, K. C., Mar 2026, In: Molecular Cancer Research. 24, 3, p. 198 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition
Devenport, J. M., Tran, T., Harris, B. R., Fingerman, D., DeWeerd, R. A., Elkhidir, L. H., LaVigne, D., Fuh, K., Sun, L., Bednarski, J. J., Drapkin, R., Mullen, M. M. & Green, A. M., Mar 10 2025, In: JCI Insight. 10, 5, e186409.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells
Lesage, J., Dimauro, A., Schab, A. M., Stidham, S., Mullen, M. M., Fuh, K. C. & Longmore, G. D., Dec 2 2025, In: Molecular Cancer Research. 23, 12, p. 1012-1024 13 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
From one-size-fits all to biology-driven care: Emerging paradigms in gynecologic oncology
Mullen, M. M. & Arend, R. C., Sep 2025, In: Gynecologic oncology. 200, p. A1-A2Research output: Contribution to journal › Editorial
-
Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response
Valentine, M. C., Mullen, M. M., Kotnik, E. N., Powell, M. A., Thaker, P. H., McCourt, C. K., Kuroki, L. M., Hagemann, A. R., Arend, R. C., Holehouse, A. S., Mitra, R., Mutch, D. G. & Fuh, K. C., Sep 15 2025, In: Cancer research. 85, 18, p. 3558-3570 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations